CTI BioPharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.08.17	CTI BioPharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference (PR Newswire)
03.08.17	EARNINGS SUMMARY: Details of CTI BioPharma Corp. Q2 Earnings Report (RTTNews)
03.08.17	CTI BioPharma Reports Second Quarter 2017 Financial Results (PR Newswire)
02.08.17	CTI BioPharma Announces Completion of Enrollment in the Phase 3 PIX306 Trial of PIXUVRI® for Aggressive B-cell non-Hodgkin lymphoma (PR Newswire)
01.08.17	CTI BioPharma Announces First Patient Enrolled in Phase 2 Trial of Pacritinib in Patients with Myelofibrosis who have Thrombocytopenia and who have been Previously Treated with Ruxolitinib (PR Newswire)
27.07.17	CTI BioPharma to Report Second Quarter 2017 Financial Results on August 3, 2017 (PR Newswire)
24.07.17	CTI BioPharma Appoints Biotechnology Industry Veteran Laurent Fischer, M.D., to Board of Directors (PR Newswire)
14.07.17	FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33% (RTTNews)
13.07.17	CTI BioPharma Announces European Medicines Agency Validation of Pacritinib Marketing Authorization Application for Patients with Myelofibrosis who have Thrombocytopenia (PR Newswire)
15.06.17	CTI BioPharma Gets $10 Mln Milestone Payment For TRISENOX From Teva (RTTNews)
15.06.17	CTI BioPharma Receives $10 Million Milestone Payment for TRISENOX® (PR Newswire)
07.06.17	FDA Panel To Review PTCT's Translarna, CTIC Plunges On Offering, NNVC Abuzz (RTTNews)
06.06.17	CTI BioPharma Prices Underwritten Public Offering of $45 Million of Convertible Preferred Stock (PR Newswire)
05.06.17	CTI BioPharma Announces Proposed Public Offering Of Convertible Preferred Stock (PR Newswire)
05.06.17	CTI BioPharma Appoints David R. Parkinson, M.D., Leader in Oncology Clinical Development, to Board of Directors and Announces Board Member Resignations (PR Newswire)
03.05.17	EARNINGS SUMMARY: Details of CTI BioPharma Corp. Q1 Earnings Report (RTTNews)
25.04.17	Servier and CTI BioPharma Expand License and Collaboration Agreement to Develop and Commercialize PIXUVRI® (PR Newswire)
02.03.17	EARNINGS SUMMARY: Details of CTI BioPharma Corp. Q4 Earnings Report (RTTNews)
02.03.17	CTI BioPharma Reports Fourth Quarter and Full Year 2016 Financial Results (PR Newswire)
27.02.17	CTI BioPharma Appoints Adam Craig As President & CEO - Quick Facts (RTTNews)
27.02.17	CTI BioPharma Announces Appointment of Hematology/Oncology Clinical Expert Adam Craig, M.D., Ph.D., as President and CEO (PR Newswire)
24.02.17	Research Reports Coverage on Biotech Stocks -- Puma Biotechnology, Dipexium Pharma, BioCryst Pharma, and CTI BioPharma (PR Newswire)
23.02.17	CTI BioPharma to Report Fourth Quarter and Full Year 2016 Financial Results on March 2, 2017 (PR Newswire)
08.02.17	CTI BioPharma to Present at the BIO CEO & Investor Conference (PR Newswire)
24.01.17	CTI Biopharma Appoints Leading BioPharma Executive Michael Metzger to board of directors (PR Newswire)
17.01.17	Technical Reports on Biotech Stocks -- ContraVir Pharma, Arena Pharma, Neuralstem, and CTI BioPharma (PR Newswire)
09.01.17	CTI BioPharma Announces Progress Of Lead Programs And Strategic Objectives For 2017 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu CTI BioPharma Corp Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten